Arf1-dependent LRBA recruitment to Rab4 endosomes is required for endolysosome homeostasis.


Journal

The Journal of cell biology
ISSN: 1540-8140
Titre abrégé: J Cell Biol
Pays: United States
ID NLM: 0375356

Informations de publication

Date de publication:
04 Nov 2024
Historique:
received: 03 02 2024
revised: 15 07 2024
accepted: 06 08 2024
medline: 26 9 2024
pubmed: 26 9 2024
entrez: 26 9 2024
Statut: ppublish

Résumé

Deleterious mutations in the lipopolysaccharide responsive beige-like anchor protein (LRBA) gene cause severe childhood immune dysregulation. The complexity of the symptoms involving multiple organs and the broad range of unpredictable clinical manifestations of LRBA deficiency complicate the choice of therapeutic interventions. Although LRBA has been linked to Rab11-dependent trafficking of the immune checkpoint protein CTLA-4, its precise cellular role remains elusive. We show that LRBA, however, only slightly colocalizes with Rab11. Instead, LRBA is recruited by members of the small GTPase Arf protein family to the TGN and to Rab4+ endosomes, where it controls intracellular traffic. In patient-derived fibroblasts, loss of LRBA led to defects in the endosomal pathway promoting the accumulation of enlarged endolysosomes and lysosome secretion. Thus, LRBA appears to regulate flow through the endosomal system on Rab4+ endosomes. Our data strongly suggest functions of LRBA beyond CTLA-4 trafficking and provide a conceptual framework to develop new therapies for LRBA deficiency.

Identifiants

pubmed: 39325073
pii: 276994
doi: 10.1083/jcb.202401167
pii:
doi:

Substances chimiques

rab4 GTP-Binding Proteins EC 3.6.5.2
LRBA protein, human EC 2.7.10.-
rab GTP-Binding Proteins EC 3.6.5.2
Adaptor Proteins, Signal Transducing 0
ARF1 protein, human EC 3.6.5.2
ADP-Ribosylation Factors EC 3.6.5.2
rab11 protein EC 3.6.1.-
ADP-Ribosylation Factor 1 EC 3.6.5.2

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Subventions

Organisme : Hilfe für krebskranke Kinder e.V.
Organisme : Swiss National Science Foundation
ID : 310030_197779
Pays : Switzerland
Organisme : University of Basel
Organisme : Goethe University Frankfurt
Organisme : Dr. Rolf Schwiete Foundation

Informations de copyright

© 2024 Szentgyörgyi et al.

Auteurs

Viktória Szentgyörgyi (V)

Biozentrum, University of Basel , Basel, Switzerland.

Leon Maximilian Lueck (LM)

Department of Pediatrics, Goethe-University Frankfurt, Frankfurt, Germany.

Daan Overwijn (D)

Biozentrum, University of Basel , Basel, Switzerland.

Danilo Ritz (D)

Biozentrum, University of Basel , Basel, Switzerland.

Nadja Zoeller (N)

Dermatology, Goethe University Frankfurt , Frankfurt, Germany.

Alexander Schmidt (A)

Biozentrum, University of Basel , Basel, Switzerland.

Maria Hondele (M)

Biozentrum, University of Basel , Basel, Switzerland.

Anne Spang (A)

Biozentrum, University of Basel , Basel, Switzerland.

Shahrzad Bakhtiar (S)

Department of Pediatrics, Goethe-University Frankfurt, Frankfurt, Germany.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH